We do have some clients in our community that are on GLP-1 RAs
Semaglutide (Wegovy): STEP-1 trial The once-weekly injectable semaglutide 2.4 mg is currently the market leader for pharmacologic weight management
Always verify that the compounding pharmacy is 503A/503B registered and compliant with USP sterile compounding standards
For people with type 2 diabetes, insufficient medication doses can lead to poor blood sugar control, potentially causing long-term complications like nerve damage, kidney problems, or cardiovascular issues
"A higher body weight causes increased pressure on your upper airways," Wojeck says
Potere Health MD does not manufacture compounded medications. Compounded formulations are not FDA-approved, have not been evaluated for safety or efficacy, and are not generic equivalents to commercial products